What is CHD Bioscience?
CHD Bioscience is a biotechnology firm headquartered in Fort Collins, Colorado, dedicated to combating hospital-acquired infections. The company focuses on the discovery, development, and commercialization of disinfectants and treatments for infectious diseases affecting both humans and animals. Their mission is to establish a leading position in preventing and treating a wide spectrum of pathogens, addressing critical public health needs in industrialized and developing nations alike. The company's commitment to innovation in infection control positions it as a key player in the bioscience sector.
How much funding has CHD Bioscience raised?
CHD Bioscience has raised a total of $10.9M across 4 funding rounds:
Private Equity
$3.2M
Private Equity
$1.7M
Private Equity
$3.3M
Private Equity
$2.7M
Private Equity (2014): $3.2M, investors not publicly disclosed
Private Equity (2015): $1.7M, investors not publicly disclosed
Private Equity (2016): $3.3M, investors not publicly disclosed
Private Equity (2017): $2.7M, investors not publicly disclosed
What's next for CHD Bioscience?
With substantial enterprise-level backing, CHD Bioscience is poised to accelerate its research and development initiatives and expand its market reach. The recent strategic investment suggests confidence from investors in the company's technology and its potential to address the growing global challenge of infectious diseases. Future endeavors will likely focus on scaling production, securing regulatory approvals, and forging strategic partnerships to bring their advanced disinfectant and treatment solutions to a wider audience, reinforcing their mission to lead in infectious disease prevention.
See full CHD Bioscience company page
